What is H.C. Wainwright's price target for COGT?

H.C. Wainwright's latest stated price target for Cogent Biosciences Inc. (COGT) is $28, from its action on Mar 27, 2023.

What is H.C. Wainwright's rating on COGT?

H.C. Wainwright rates COGT Buy, a bullish rating, as of Mar 27, 2023.

When did H.C. Wainwright last change its view on COGT?

On Mar 27, 2023, H.C. Wainwright resumes coverage at Buy, price target $28.

Analyst firms · H.C. Wainwright · COGT

H.C. Wainwright COGT price target and rating history

Cogent Biosciences Inc. (COGT) · Health Care

H.C. Wainwright rates Cogent Biosciences Inc. (COGT) Buy with a $28 price target, as of its latest action on Mar 27, 2023. It has published 3 rating actions on COGT since October 2021, including 0 upgrades and 0 downgrades.

Current rating: Buy
Price target: $28
Median target, all firms: Too few
Actions on COGT: 3

H.C. Wainwright price target on COGT

H.C. Wainwright price target on COGT, each point a stated target, October 2021 to March 2023.

Every H.C. Wainwright rating on COGT

Mar 27, 2023
ResumeH.C. Wainwright resumes coverage at Buy, price target $28
Nov 5, 2021
ReiterateH.C. Wainwright raises its price target to $31 from $25, keeps Buy
Oct 11, 2021
InitiateH.C. Wainwright starts coverage at Buy, price target $25

How other firms rate COGT

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Jefferies	Buy		Mar 16, 2026
Stifel	Buy	$40	Nov 10, 2025
Wedbush	Outperform	$38	Nov 10, 2025

Questions about H.C. Wainwright and COGT

What is H.C. Wainwright's price target for COGT?: H.C. Wainwright's latest stated price target for Cogent Biosciences Inc. (COGT) is $28, from its action on Mar 27, 2023.
What is H.C. Wainwright's rating on COGT?: H.C. Wainwright rates COGT Buy, a bullish rating, as of Mar 27, 2023.
When did H.C. Wainwright last change its view on COGT?: On Mar 27, 2023, H.C. Wainwright resumes coverage at Buy, price target $28.

All H.C. Wainwright ratings COGT news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.